|
BETonMACE baseline data
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 12:11PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 01:51PM
|
|
Zacks SCR Report 9/19/2016
|
3
|
Resverlogix Corp.
|
Sep 21, 2016 01:21PM
|
|
Re: Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
3
|
Resverlogix Corp.
|
Oct 26, 2015 05:55PM
|
|
Re: Looking for clues:
|
3
|
Resverlogix Corp.
|
Nov 30, 2019 10:59AM
|
|
The HDL hypothesis lives on
|
3
|
Resverlogix Corp.
|
Dec 18, 2018 07:50PM
|
|
Re: FA
|
3
|
Resverlogix Corp.
|
Oct 02, 2017 03:56PM
|
|
Re: ...Crunch time..
|
3
|
Resverlogix Corp.
|
Sep 22, 2015 01:50PM
|
|
Re: There is a positive side to the news...
|
3
|
Resverlogix Corp.
|
Mar 19, 2018 01:03PM
|
|
Re: An ESC video from youtube that mentions Apabetalone, posted July 10 2019
|
3
|
Resverlogix Corp.
|
Sep 10, 2019 01:59PM
|
|
Re: Statistically proven...
|
3
|
Resverlogix Corp.
|
Sep 12, 2019 10:46PM
|
|
Zenith presenting at 12th Annual BIOTECanada Investor Summit
|
3
|
Zenith Epigenetics
|
Feb 18, 2016 09:41PM
|
|
Re: BIO Europe
|
3
|
Zenith Epigenetics
|
Nov 05, 2018 12:32PM
|
|
AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 09, 2018 08:43AM
|
|
News Release from ERA-EDTA Conference
|
3
|
Resverlogix Corp.
|
Jun 01, 2015 08:12AM
|
|
Re: Adjudication
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 07:48PM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
3
|
Resverlogix Corp.
|
May 11, 2016 09:02PM
|
|
Targeting bromodomain and extraterminal proteins in breast cancer
|
3
|
Zenith Epigenetics
|
Nov 27, 2017 12:41PM
|
|
Re: Japanese publication response from IR
|
3
|
Zenith Epigenetics
|
Nov 12, 2016 03:50PM
|
|
Re: The day is not over yet....
|
3
|
Resverlogix Corp.
|
Jun 11, 2018 01:56PM
|
